Delaware Arthritis /ID# 230110 — Lewes, Delaware

Delaware Arthritis /ID# 230110 is a clinical research site located in Lewes, Delaware, United States 19958.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Delaware Arthritis /ID# 230110 has participated in 1 clinical trials.

Therapeutic areas: Polymyalgia Rheumatica.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lewes

Browse all research sites in Delaware · View every site in Lewes

• Beebe Medical Center
• Tunnell Cancer Center at Beebe Medical Center
• Delaware Arthritis
• Research Site
• Investigational Site Number 840130
• Rheumatology Consultants of Delaware dba Delaware Arthritis
• Rheumatology Consultants of Delaware
• Rheumatolgy Consultants of Deleware
• 111
• Delaware Arthritis /ID# 142803
• 218
• Beebe Healthcare Tunnell Cancer Center

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Delaware Arthritis /ID# 230110?

Delaware Arthritis /ID# 230110 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Delaware Arthritis /ID# 230110 conducted?

Delaware Arthritis /ID# 230110 has 1 clinical trials on record. Their work covers Polymyalgia Rheumatica.

Is Delaware Arthritis /ID# 230110 accredited by Crixeo Clinical Trials?

Delaware Arthritis /ID# 230110 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Delaware Arthritis /ID# 230110?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.